Rebecca Weil

Rebecca Weil

Corporate Officer/Principal bij OCULIS HOLDING AG
Health Technology
Finance
Consumer Services

Profiel

Rebecca Weil currently works at Oculis Holding AG, as Chief Commercial Officer from 2023.
Dr. Weil also formerly worked at Juvenile Diabetes Research Foundation (New York), as Director, Bausch + Lomb Corp., as Global Head-Marketing, Strategy & Pharmaceuticals, Idorsia Ltd., as Head-Global Marketing from 2019 to 2023, Shire Plc, as Group Vice President & Head-Corporate Affairs from 2018 to 2019, and Alcon AG, as Vice President & Head-Western Europe.
Dr. Weil received her doctorate degree from Massachusetts Institute of Technology and undergraduate degree from Princeton University.

Actieve functies van Rebecca Weil

BedrijvenFunctieBegin
OCULIS HOLDING AG Corporate Officer/Principal 11-09-2023

Eerdere bekende functies van Rebecca Weil

BedrijvenFunctieEinde
IDORSIA LTD Verkoop & Marketing 01-08-2023
SHIRE Corporate Officer/Principal 01-03-2019
Juvenile Diabetes Research Foundation (New York)
Directeur/Bestuurslid -
BAUSCH + LOMB CORPORATION Verkoop & Marketing -
NOVARTIS AG Corporate Officer/Principal -
Ervaring van Rebecca Weil in detail bekijken

Opleiding van Rebecca Weil

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

29

Eerstegraads connecties

9

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit9

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Health Technology

Juvenile Diabetes Research Foundation (New York)

Health Technology

Commercial Services

  1. Beurs
  2. Insiders
  3. Rebecca Weil